PADAKONN PHARMA OÜ
Date of report 17.03.2025
Open the reports you want to print
Employees and salaries
PADAKONN PHARMA OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
PADAKONN PHARMA OÜ
Decision-makers?
Relations: 5
Turnover 2024: 593 780 €
Employees: 3
Kirill Smirnov
★★★★
......
Credit Score: Neutral
Reputation score: 3270
Date of birth: ......
Active relations 5
*Every member of the management board may represent the private limited company in concluding all transactions.
PADAKONN PHARMA OÜ
History of right of representation?
Field
Professional Activities
Business age
5y
Beneficial country:
Estonia
Kirill Smirnov ... - ...
2020
2021
2022
2023
2024
2025
2020
2021
2022
2023
2024
2025
PADAKONN PHARMA OÜ
Owners?
Former owners
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
PADAKONN PHARMA OÜ
GoodwillPADAKONN PHARMA OÜ
Taxes paid and estimated average salariesPADAKONN PHARMA OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
PADAKONN PHARMA OÜ
Sales revenue by business areaPADAKONN PHARMA OÜ
Sales revenue by countryPADAKONN PHARMA OÜ
Financial indicators and prognosisPADAKONN PHARMA OÜ
Financial raiting: "VERY GOOD" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
PADAKONN PHARMA OÜ
Real estate as of 17.03.2025
PADAKONN PHARMA OÜ
Annual reportsLiabilities and debts
PADAKONN PHARMA OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
PADAKONN PHARMA OÜ
Reports and assets-liabilities overview 17.03.2025?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
PADAKONN PHARMA OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
PADAKONN PHARMA OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
PADAKONN PHARMA OÜ
Bailiff's enforcement proceedings as of 17.03.2025?
Bailiff's enforcement proceedings MISSING
PADAKONN PHARMA OÜ
Regulations of the Payment Order Department as of 17.03.2025?
Regulations of the Payment Order Department MISSING
PADAKONN PHARMA OÜ
Court orders in the register as of 17.03.2025?
Puuduste kõrvaldamise määrus
12.03.2025
Regulation number: Ä 50139625 / M2
Regulation status has entered into force: 12.03.2025
Regulation status: Allkirjastatud
Korraldav määrus
22.05.2020
Regulation number: Ä 50139625 / M1
Regulation status has entered into force: 22.05.2020
Date of enforcement of order or additional period: 22.05.2020
Regulation status: Jõustunud
PADAKONN PHARMA OÜ
Decisions of the Consumer Disputes Committee as of 17.03.2025?
Consumer disputes MISSING
PADAKONN PHARMA OÜ
Court hearings as of 17.03.2025?
Court hearings MISSING
PADAKONN PHARMA OÜ
Rulings as of 17.03.2025?
Court settlemets MISSING
PADAKONN PHARMA OÜ
Notices and announcements as of 17.03.2025?
Announcements MISSING
Marketing
Business network
PADAKONN PHARMA OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
PADAKONN PHARMA OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.